Is There an Ideal Donor Site of Fat for Secondary Breast Reconstruction?

Monday, April 15, 2013: 10:15 AM
Kevin Small, MD, Institute of Reconstructive Plastic Surgery, NY Presbyterian Hospital-Cornell, New York, NY, Oriana Petruolo, MD, Plastic Surgery, New York University School of Medicine, New York, NY, Mihye Choi, MD, Institute of Reconstructive Plastic Surgery, New York University School of Medicine, New York, NY and Nolan S. Karp, MD, Institute of Reconstructive Plastic Surgery, New York University, New York, NY
Goals/Purpose:

Previous work has documented the validity of three-dimensional imaging to assess surgical outcomes of autologous fat grafting (FG). However, no study currently exists to delineate the ideal donor site of fat for secondary breast reconstruction. Millard argued in Principilization of Plastic Surgery that tissue losses should be replaced in kind; thus, theoretically, plastic surgeons should harvest adipose tissue from neighboring donor sites to optimize aesthetic results. The following study compares fat graft survival from two distinctive anatomical sites utilizing three-dimensional imaging.

Methods/Technique:

All patients receiving fat grafting to the reconstructed breast from 2009-2012 were enrolled in the study. The patients were divided into two groups depending on the donor site: Group A for fat harvested from the abdomen and Group B from the thighs.  FG surgery was performed using a modified Coleman technique to achieve symmetry. Preoperative and post-operative 3D scans were obtained on all patients. 3D imaging was performed using the Canfield VECTRA system and analyzed using Geomagic software. As previously described, breasts were isolated as closed objects and total breast volume was calculated on every scan.

Results/Complications:

In the observed time period, a total of 88 patients (135 breasts) received autologous fat transfer and were evaluated with three-dimensional images.  46 patients (66 breasts) averaged 101.17cc of fat injected from the abdomen (Group A), and 27 patients (43 breasts) averaged 101.98cc of fat injected from the thighs (Group B). The patients who received fat graft from both the abdomen and thighs were excluded from the study (15 patients, 26 breasts).  The abdominal subset had 86.70% volume retention at 7 days postoperatively, 81.98% volume retention at 16 days, 63.15% volume retention at 49 days, and 44.63% volume retention at 140 days.  The thigh subset had 94.56% volume retention at 7 days postoperatively, 85.80% volume retention at 16 days, 62.71% volume retention at 49 days, and 46.43% volume retention at 140 days.  No statistical difference was found between these two groups for any of the time periods.

Conclusion:

The following study applies 3D imaging technology to analyze objective changes in breast volume following autologous fat transfer from two major donor sites.  Our data suggests that the fat graft donor site does not affect percent volume retention. Longer-term studies are needed to assess the stability of the breast after autologous fat transfer.